Acesse online as principais diretrizes médicas, nacional e internacional, no campo da Cardiologia, em 2017:
■ Guideline for the management of patients with valvular heart disease
A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideline
R A Nishimura, C M Otto, R O Bonow et al
Circulation 2017, vol 135: e11159-e1195
http://circ.ahajournals.org/content/135/25/e1159
■ Current guidelines on prevention with a focus on dyslipidemias
Ian M. Graham, Alberico L. Catapano, Nathan D. Wong
Cardiovasc Diagn Ther. 2017 Apr; 7(Suppl 1): S4–S10
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418212/
■ Prevention of cardiovascular complications in patients with Lp(a) hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines
Reinhard Klingel, Andreas Heibges, Cordula Fassbender, Pro(a)LiFe-Study Group
Clin Res Cardiol Suppl. 2017; vol 12(Suppl 1): 38–43
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352778/
■ Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease
A Scientific Science advisory From American Heart Association
D S Siscovick, T A Barringer, A M Fretts et al
Circulation 2017, vol 135: e867-884
http://circ.ahajournals.org/content/135/15/e867
■ Meal timing and frequency: implications for cardiovascular disease prevention
A Scientific Statement From American Heart Association
M St-Onge, J Ard, M L Baskin et al
Circulation 2017, vol 135: e96-e121
http://circ.ahajournals.org/content/135/9/e96
■ Heart failure in patients with coronary heart disease: prevalence, characteristics and guideline implementation – results from the German EuroAspire IV cohort
Caroline Morbach, Martin Wagner, Stefan Güntner et al
BMC Cardiovasc Disord. 2017; vol 17: 108
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420109/
■ Role of biomarkers for the prevention, assessment, and management of heart failure:
A Scientific Statement From the American Heart Association
S L Chow, A S Fonrow, B Greenberg et al
Circulation 2017, vol 135: e1054-e1091
http://circ.ahajournals.org/content/135/22/e1054
■ Recommendation for the use of mechanical circulatory support: ambulatory and community patient care
A Scientific Statement From the American Heart Association
J L Cook, M Colvin, G S Francis et al
Circulation 2017, vol 135: e11145-e1158
http://circ.ahajournals.org/content/135/25/e1145
■ Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease
A Scientific Statement For Health Professionals From American Heart Association
D E Forman, R Arena, R Boxer et al
Circulation 2017, vol 135: e849- e918
http://circ.ahajournals.org/content/135/16/e894
■ Management of patients on non-vitamin K antagonists oral anticoagulants in the acute care and periprocedural setting
A Scientific Statement From American Heart Association
A N Raval, J E Cigarroa, M K Chung et al
Circulation 2017, vol 135: e604-e633
http://circ.ahajournals.org/content/135/10/e604
■ Cardiovascular care guideline implementation in community health center in Oregon: a mixed-methods analysis of real-world barriers and challenges
Rachel Gold, Arwen Bunce, Stuart Cowburn et al
BMC Health Serv Res. 2017; vol 17: 25
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382420/
■ Exploration of the methodological quality and clinical usefulness of a cross-sectional sample of published guidance about exercise training and physical activity for the secondary prevention of coronary heart disease
Bridget Abell, Paul Glasziou, Tammy Hoffmann
BMC Cardiovasc Disord. 2017; vol 17: 15
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470313/
■ Telemedicine in pediatric cardiology
A Scientific Statement From American Heart Association
G M Satou, K Rheuban, D Alverson et al
Circulation 2017, vol 135: e648-e678
http://circ.ahajournals.org/content/135/11/e648
■ Cardiopulmonry resuscitation in adults and children with mechanical circulatory support
A Scientific Statement From the American Heart Association
M A Peberdy, J A Gluck, J P Ornato et al
Circulation 2017, vol 135: e1115-e1134
http://circ.ahajournals.org/content/135/24/e1115
■ Added sugars and cardiovascular disease risk in children
A Scientific Statement From the American Heart Association
M B Vos, J L Kaar, J A Welsh, L v Van Horn et al
Circulation 2017, vol 135: e1017-1034
http://circ.ahajournals.org/content/135/19/e1017
■ Diagnosis, treatement, and long-term management of Kawasaki disease
A Scientific Statement For Health Professionals From American Heart Association
B W McCrindle, A H Rowley, J W Newburger et al
Circulation 2017, vol 135: e927- e999
http://circ.ahajournals.org/content/135/17/e927
■ Management of pregnancy in patients with complex congenital heart disease
A Scientific Statement For Healthcare Professionals From American Heart Association
M M Canobbio, C A Warnes, J Aboulhosn et al
Circulation 2017, vol 135: e50-e8
http://circ.ahajournals.org/content/135/8/e50
■ A mobile clinical decision support tool for pediatric cardiovascular risk-reduction clinical practice guidelines: development and description
Robert D Furberg, Pamela Williams, Jacqueline Bagwell, Kenneth LaBresh
JMIR Mhealth Uhealth. 2017 Mar; vol 5(3): e29.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378042/
■ Adherence to quideline for creatine and potassium monitoring and discontinuation following rennin-angiotensin system blockade: a UK general practive-based cohort study
Morten Schmidt, Kathryn E Mansfield, Krishnan Bhaskaran et al
BMJ Open. 2017; 7(1): e01281
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223644/
■ Nationl guidelines for smoking cessation in primary care: a literature review and evidence analysis
Marjolein Verbiest, Evelyn Brakema, Rianne van der Kleij et al
NPJ Prim Care Respir Med. 2017; 27: 2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434788/
